- Industry
- 1 min read
FDA identifies recall of Emergent's decontamination kits as most serious
The contract manufacturer began the recall of 3,500 units of the kit in November, after receiving three customer complaints of leakage from the packets. No serious injuries or deaths related to the issue were reported. FDA says the leakage could cause loss or drying out of the lotion content, reducing the effectiveness of the kit and prolonged exposure to the leaked lotion.
The contract manufacturer began the recall of 3,500 units of the kit in November, after receiving three customer complaints of leakage from the packets. No serious injuries or deaths related to the issue were reported.
Emergent had recalled kits with distribution dates between Oct. 4 and Oct. 14, 2022. The company on Thursday said it was working towards concluding the voluntary recall.
The company's investigation showed that all kits, other than the recalled lots, met quality criteria and were suitable for use, Emergent said in a statement to Reuters.
The kits are carried by members of the military and are intended to remove chemical warfare agents and harmful T-2 toxin from the skin.
FDA says the leakage could cause loss or drying out of the lotion content, reducing the effectiveness of the kit and prolonged exposure to the leaked lotion.
Damaged lotion content could also make an individual, already exposed to chemical warfare, more vulnerable to health hazards.
Shares of the company were down more than 2 per cent in afternoon trade.
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions